COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest NewsPDA Students   »   Student Newsletter – May 2022

Student Newsletter – May 2022

In this edition, read about top tips that can benefit you while preparing for exams, what it is like to be a PDA Student Rep, and the PDA’s advice for returning to in-person examinations.

Sat 7th May 2022 The PDA

In this months issue:

  • PDA meets pharmacy students at the BPSA 80th Annual Conference
  • Top tips from PDA Student Reps on preparing for exams
  • Pharmacy students return to in-person examinations
  • Being a PDA Student Rep
  • PDA takes part in Pharmacist Support’s ACTnow Campaign
  • Campaigning & Organising workshop
  • Getting in touch

DOWNLOAD THE May issue here

thumbnail of May Student Newsletter

 

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)